The low-abundance transcriptome reveals novel biomarkers, specific intracellular pathways and targetable genes associated with advanced gastric cancer

International Journal of Cancer

Volumn 134, Issue 4, 2014, Pages 755-764

  Bizama, Carolina ^a,b   Benavente, Felipe ^a,b   Salvatierra, Edgardo ^c   Gutiérrez Moraga, Ana ^a,b   Espinoza, Jaime A ^a   Fernández, Elmer A ^d   Roa, Iván ^b   Mazzolini, Guillermo ^e   Sagredo, Eduardo A ^a   Gidekel, Manuel ^a,b,f   Podhajcer, Osvaldo L ^c  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b Creative Bioscience   (Chile)

^c FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^d UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

^e UNIVERSIDAD AUSTRAL   (Argentina)

^f NONE   (Chile)

Author keywords

CTBP1 and chemotherapy sensitization; gastric cancer; low abundance transcriptome; novel biomarkers and therapeutic targets; specific intracellular pathways

Indexed keywords

BINDING PROTEIN; BIOLOGICAL MARKER; C TERMINAL OF E1A BINDING PROTEIN; CISPLATIN; CONNECTIN; EPIRUBICIN; FLUOROURACIL; FRIZZLED FAMILY RECEPTOR 5; FRIZZLED PROTEIN; GAMMA INTERFERON; INSULIN RECEPTOR SUBSTRATE 2; INTERLEUKIN 17; LAMININ; LAMININ ALPHA 3; TRANSCRIPTOME; UNCLASSIFIED DRUG; VASCULOTROPIN C; WNT 1 INDUCED SECRETED PROTEIN 1; WNT1 PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIZATION; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RNA ANALYSIS; RNA HYBRIDIZATION; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR GENE;

EID: 84890128817     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28405     Document Type: Article

References (44)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
3. Fornaro L, Lucchesi M, Caparello C, et al. Anti-HER agents in gastric cancer: from bench to bedside. Nat Rev Gastroenterol Hepatol 2011; 8: 369-83.
4. Jorgensen JT, Hersom M,. HER2 as a prognostic marker in gastric cancer-a systematic analysis of data from the literature. J Cancer 2012; 3: 137-44.
5. Cui J, Chen Y, Chou WC, et al. An integrated transcriptomic and computational analysis for biomarker identification in gastric cancer. Nucleic Acids Res 2011; 39: 1197-207.
6. Graveley BR, Brooks AN, Carlson JW, et al. The developmental transcriptome of Drosophila melanogaster. Nature 2011; 471: 473-9.
7. Diatchenko L, Lau YF, Campbell AP, et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 1996; 93: 6025-30.
8. Pan YS, Lee YS, Lee YL, et al. Differentially profiling the low-expression transcriptomes of human hepatoma using a novel SSH/microarray approach. BMC Genomics 2006; 7: 131.
9. Liu Y, Zhu X, Zhu J, et al. Identification of differential expression of genes in hepatocellular carcinoma by suppression subtractive hybridization combined cDNA microarray. Oncol Rep 2007; 18: 943-51.
10. Liu BH, Goh CH, Ooi LL, et al. Identification of unique and common low abundance tumour-specific transcripts by suppression subtractive hybridization and oligonucleotide probe array analysis. Oncogene 2008; 27: 4128-36.
11. Barraclough DL, Sewart S, Rudland PS, et al. Microarray analysis of suppression subtracted hybridisation libraries identifies genes associated with breast cancer progression. Cell Oncol 2010; 32: 87-99.
12. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.
13. Defilles C, Lissitzky JC, Montero MP, et al. alphavbeta5/beta6 integrin suppression leads to a stimulation of alpha2beta1 dependent cell migration resistant to PI3K/Akt inhibition. Exp Cell Res 2009; 315: 1840-9.
14. Ning Y, Manegold PC, Hong YK, et al. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int J Cancer 2011; 128: 2038-49.
15. Hamill KJ, Paller AS, Jones JC,. Adhesion and migration, the diverse functions of the laminin alpha3 subunit. Dermatol Clin 2010; 28: 79-87.
16. Labeit D, Watanabe K, Witt C, et al. Calcium-dependent molecular spring elements in the giant protein titin. Proc Natl Acad Sci USA 2003; 100: 13716-21.
17. Pfohler C, Preuss KD, Tilgen W, et al. Mitofilin and titin as target antigens in melanoma-associated retinopathy. Int J Cancer 2007; 120: 788-95.
18. Huang da W, Sherman BT, Lempicki RA,. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57.
19. Thomas PD, Kejariwal A, Campbell MJ, et al. PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res 2003; 31: 334-41.
20. Boyd JM, Subramanian T, Schaeper U, et al. A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J 1993; 12: 469-78.
21. Birts CN, Harding R, Soosaipillai G, et al. Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance. Biol Cell 2010; 103: 1-19.
22. Bertucci F, Salas S, Eysteries S, et al. Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters. Oncogene 2004; 23: 1377-91.
23. Ii M, Yamamoto H, Taniguchi H, et al. Co-expression of laminin beta3 and gamma2 chains and epigenetic inactivation of laminin alpha3 chain in gastric cancer. Int J Oncol 2011; 39: 593-9.
24. Machado C, Andrew DJ,. D-Titin: a giant protein with dual roles in chromosomes and muscles. J Cell Biol 2000; 151: 639-52.
25. Machado C, Sunkel CE, Andrew DJ,. Human autoantibodies reveal titin as a chromosomal protein. J Cell Biol 1998; 141: 321-33.
26. Zastrow MS, Flaherty DB, Benian GM, et al. Nuclear titin interacts with A- and B-type lamins in vitro and in vivo. J Cell Sci 2006; 119: 239-49.
27. Greenman C, Stephens P, Smith R, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007; 446: 153-8.
28. Stacker SA, Achen MG, Jussila L, et al. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002; 2: 573-83.
29. Feng LZ, Zheng XY, Zhou LX, et al. Correlation between expression of S100A4 and VEGF-C, and lymph node metastasis and prognosis in gastric carcinoma. J Int Med Res 2011; 39: 1333-43.
30. Lu Y, Lu P, Zhu Z, et al. Loss of imprinting of insulin-like growth factor 2 is associated with increased risk of lymph node metastasis and gastric corpus cancer. J Exp Clin Cancer Res 2009; 28: 125.
31. Han CH, Cho JY, Moon JT, et al. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer. Oncol Rep 2006; 16: 1205-10.
32. Schnarr B, Strunz K, Ohsam J, et al. Down-regulation of insulin-like growth factor-I receptor and insulin receptor substrate-1 expression in advanced human breast cancer. Int J Cancer 2000; 89: 506-13.
33. Dearth RK, Cui X, Kim HJ, et al. Oncogenic transformation by the signaling adaptor proteins insulin receptor substrate (IRS)-1 and IRS-2. Cell Cycle 2007; 6: 705-13.
34. Algood HM, Gallo-Romero J, Wilson KT, et al. Host response to Helicobacter pylori infection before initiation of the adaptive immune response. FEMS Immunol Med Microbiol 2007; 51: 577-86.
35. Jovanovic DV, Di Battista JA, Martel-Pelletier J, et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol 1998; 160: 3513-21.
36. Iida T, Iwahashi M, Katsuda M, et al. Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Oncol Rep 2011; 25: 1271-7.
37. Dunn GP, Koebel CM, Schreiber RD,. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006; 6: 836-48.
38. Nishikawa H, Kato T, Tawara I, et al. IFN-gamma controls the generation/activation of CD4+ CD25+ regulatory T cells in antitumor immune response. J Immunol 2005; 175: 4433-40.
39. Katoh M,. Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer. Cancer Biol Ther 2007; 6: 832-9.
40. Katoh M,. STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer (Review). Int J Mol Med 2007; 19: 273-8.
41. Kurayoshi M, Oue N, Yamamoto H, et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer Res 2006; 66: 10439-48.
42. Price RM, Tulsyan N, Dermody JJ, et al. Gene expression after crush injury of human saphenous vein: using microarrays to define the transcriptional profile. J Am Coll Surg 2004; 199: 411-8.
43. Zhang Q, Wang SY, Nottke AC, et al. Redox sensor CtBP mediates hypoxia-induced tumor cell migration. Proc Natl Acad Sci USA 2006; 103: 9029-33.
44. Jin W, Scotto KW, Hait WN, et al. Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cells. Biochem Pharmacol 2007; 74: 851-9.